An online initiative of the Cancer Institute NSW

NSW Oncology Group: successes and opportunities

Industry news
Share this page Email this page to a friend Share this page via Twitter Share this page via Facebook Share this page via LinkedIn

The NSW Oncology Group (NSWOG) Program was formed in August 2005 and comprises 20 groups, engaging over 700 of the State's leading cancer clinicians, health professionals, researchers, consumers and planners.

NSW Oncology Group: successes and opportunities

Groups are based on cancer type or clinical grouping and comprise active and interest members to accommodate the varying level of involvement individuals wish to have in the decisions and activities of the Group.

There have been approximately 270 meetings in the four years from the first NSWOG in September 2005 to September 2009.

Purpose

Evaluation of the NSWOG Program was undertaken to examine its delivery on the objectives defined by the NSW Cancer Plans - specialised best practice, clinical data, education and professional development, clinical trials and protocols and guidelines.

Methods

NSWOG evaluation methodology

The strength of the NSWOG Program is the collective expertise of its members, representing multidisciplinary collaboration across NSW.

Applied to a clearly defined and mutually beneficial program or project, this expertise is an invaluable service.

Results

  • Nine NSWOGs amended the Victorian Patient Management Frameworks to reflect the NSW setting.
  • Six dataset extensions to the cancer minimum dataset were developed and two extensions piloted across NSW.
  • Seven clinical indicator suits were developed by NSWOG.
  • Four NSWOGs supported the development of synoptic pathology reporting.
  • NSWOG reviewed 2 Cancer Council NSW booklets co-branding with the Cancer Institute NSW.
  • Eleven NSWOGs completed priority projects.
  • NSWOG attendance in 2007 was 34.3 per cent with 44 per cent of survey respondents citing "clinical load interfering with availability" as the primary reason for non-attendance. Following invitation to non-attendees to change their membership status from active (attending meetings) to interest (receiving meeting papers only), 92 per cent accepted the opportunity, increasing the average attendance in 2008 to 47 per cent.

Member attendance by NSWOG, 2007 and 2008

Member attendance by NSWOG, 2007 and 2008

NSWOG Achievements

Project NSW Oncology Groups
Amendment of Victorian Patient Management Frameworks to NSW setting
  • Breast
  • Colorectal
  • Haematology Oncology
  • Head and Neck
  • Lung
  • Melanoma
  • Neuro-Oncology
  • Upper GI
  • Urology
Draft additions to the Minimum Dataset (MDS) Developed
  • Haematology Oncology
  • Head and Neck
  • Lung
  • Upper GI
Piloted dataset extensions
  • Breast
  • Colorectal
Clinical Indicator Suites developed
  • Breast
  • Colorectal
  • Lung
  • Lymphoma
  • Melanoma
  • Upper GI
  • Urology
Synoptic Pathology Reporting - Collaborative Projects
  • Breast
  • Colorectal
  • Melanoma
  • Urology
Co-branded Patient Information Resources with The Cancer Council NSW
  • Complementary Therapies
  • Head and Neck
NSWOG Priority Projects
  • Bone and Soft Tissue Sarcoma
  • Breast
  • Cancer Genetics
  • Colorectal
  • Child and Adolescent (AYA and Survivorship)
  • Haematology Oncology
  • Head and Neck
  • Lung
  • Melanoma
  • Neuro-Oncology
  • Upper GI
  • Urology

Conclusion

NSWOGs have successfully provided clinical advice to the Cancer Institute NSW in areas aligned with the terms of reference of the program and applied their collective knowledge to several concepts and projects. NSWOG members need to be engaged through action and progress of issues important to each Group.

Top of page